Gensight Biologics SA is a clinical-stage biotechnology group discovering and developing novel therapies for neurodegenerative retinal diseases and diseases of the central nervous system... Show more
Industry Biotechnology
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| SPBC | 36.94 | 0.40 | +1.09% |
| Simplify US Equity PLUS Bitcoin Stgy ETF | |||
| KJAN | 36.10 | 0.26 | +0.72% |
| Innovator US Small Cap Pwr Buff ETF™ Jan | |||
| UAPR | 30.02 | 0.09 | +0.29% |
| Innovator U.S. Equity Ultra BffrETF™-Apr | |||
| EFV | 59.07 | 0.07 | +0.12% |
| iShares MSCI EAFE Value ETF | |||
| BTZ | 10.73 | -0.06 | -0.56% |
| BlackRock Credit Allocation Income Trust | |||
A.I.dvisor indicates that over the last year, GSGTF has been loosely correlated with HRTX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if GSGTF jumps, then HRTX could also see price increases.
| Ticker / NAME | Correlation To GSGTF | 1D Price Change % | ||
|---|---|---|---|---|
| GSGTF | 100% | N/A | ||
| HRTX - GSGTF | 45% Loosely correlated | +5.69% | ||
| RPTX - GSGTF | 34% Loosely correlated | +4.90% | ||
| GOSS - GSGTF | 30% Poorly correlated | -1.59% | ||
| BVAXF - GSGTF | 29% Poorly correlated | +1.02% | ||
| SPRC - GSGTF | 29% Poorly correlated | +8.22% | ||
More | ||||